Showing results (61-70 of 127) with videos related to

Sort By:
Pageof 13
Biochemical and Biophysical Research Communications|June 2, 2009
Involvement of afadin in the formation and remodeling of synapses in the hippocampusTakashi Majima, Hisakazu Ogita, Tomohiro Yamada, et al.
The Biochemical Journal|November 25, 2003
An activating mutant of Rac1 that fails to interact with Rho GDP-dissociation inhibitor stimulates membrane ruffling in mammalian cellsPayal N Gandhi, Richard M Gibson, Xiaofeng Tong, et al.
DEN Open|January 22, 2026
Clinical Significance of Endoscopic Improvement at 6 Months in Patients With Ulcerative Colitis Treated With Ustekinumab: A Retrospective Real-world AnalysisHiromu Morikubo, Minoru Matsuura, Haruka Komatsu, et al.
Gastro Hep Advances|January 2, 2026
Impact of Mediterranean Fever Gene Mutations on Clinical Characteristics in Patients With Inflammatory Bowel DiseaseTomoya Nakamura, Kohei Wagatsuma, Yuki Hayashi, et al.
Scientific Reports|July 29, 2025
Comparative study of gastric microbiota between patients with autoimmune gastritis and those with atrophic gastritisKengo Tokunaga, Sawako Miyoshi, Fuhito Hojo, et al.
Cell Reports|July 13, 2017
Peripartum Antibiotics Promote Gut Dysbiosis, Loss of Immune Tolerance, and Inflammatory Bowel Disease in Genetically Prone OffspringJun Miyoshi, Alexandria M Bobe, Sawako Miyoshi, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|April 24, 2018
Time-, Sex-, and Dose-Dependent Alterations of the Gut Microbiota by Consumption of Dietary Daikenchuto (TU-100)Jun Miyoshi, Kentaro Nobutani, Mark W Musch, et al.
The Journal of Biological Chemistry|May 3, 2007
Up-regulation of loricrin expression by cell adhesion molecule nectin-1 through Rap1-ERK signaling in keratinocytesKotaro Wakamatsu, Hisakazu Ogita, Noriko Okabe, et al.
Molecular Biology of the Cell|March 3, 2007
Dynamic regulation of p53 subnuclear localization and senescence by MORC3Keiko Takahashi, Naofumi Yoshida, Naoko Murakami, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|September 29, 2021
Clinical response of vedolizumab at week 6 predicted endoscopic remission at week 24 in ulcerative colitisDaisuke Saito, Minoru Matsuura, Ryo Ozaki, et al.
Pageof 13